These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38875863)

  • 1. Beyond biopsy for neurosarcoidosis: A review of blood and CSF biomarkers.
    Lackey E; Shen J; Sharma A; Eckstein C
    J Neuroimmunol; 2024 Aug; 393():578394. PubMed ID: 38875863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis.
    Otto C; Wengert O; Unterwalder N; Meisel C; Ruprecht K
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32393650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF-ACE activity in probable CNS neurosarcoidosis.
    Tahmoush AJ; Amir MS; Connor WW; Farry JK; Didato S; Ulhoa-Cintra A; Vasas JM; Schwartzman RJ; Israel HL; Patrick H
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Oct; 19(3):191-7. PubMed ID: 12405488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Search for biomarkers of neurosarcoidosis by proteomic analysis of cerebrospinal fluid.
    Taibi L; Boursier C; Clodic G; Bolbach G; Bénéteau-Burnat B; Vaubourdolle M; Baudin B
    Ann Biol Clin (Paris); 2017 Aug; 75(4):393-402. PubMed ID: 28751284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis.
    Bridel C; Courvoisier DS; Vuilleumier N; Lalive PH
    J Neuroimmunol; 2015 Aug; 285():1-3. PubMed ID: 26198911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study.
    Arun T; Pattison L; Palace J
    Neurology; 2020 Jun; 94(24):e2545-e2554. PubMed ID: 32354749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis.
    Khoury J; Wellik KE; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2009 Mar; 15(2):108-11. PubMed ID: 19276791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis.
    Jones DB; Mitchell D; Horn DB; Edwards CR
    Scott Med J; 1991 Oct; 36(5):144-5. PubMed ID: 1664971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin I-converting enzyme in cerebrospinal fluid and neurosarcoidosis].
    Baudin B; Bénéteau-Burnat B; Vaubourdolle M
    Ann Biol Clin (Paris); 2005; 63(5):475-80. PubMed ID: 16230281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid CD4
    Nordström S; Andersson B; Malmeström C
    Acta Neurol Scand; 2020 Nov; 142(5):480-485. PubMed ID: 32533774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
    Chazal T; Costopoulos M; Maillart E; Fleury C; Psimaras D; Legendre P; Pineton de Chambrun M; Haroche J; Lubetzki C; Amoura Z; Legarff-Tavernier M; Cohen Aubart F
    Eur J Neurol; 2019 Oct; 26(10):1274-1280. PubMed ID: 31021023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of neurosarcoidosis--necessity of biopsy.
    Stjepanović MI; Vucinić VM; Jovanović D; Mijajlović M; Trifunović VS; Stjepanović MM
    Med Pregl; 2014; 67(3-4):97-9. PubMed ID: 24961051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme in cerebrospinal fluid: a new assay.
    Oksanen V; Fyhrquist F; Somer H; Grönhagen-Riska C
    Neurology; 1985 Aug; 35(8):1220-3. PubMed ID: 2991815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurosarcoidosis: diagnosis, therapy and biomarkers.
    Bagnato F; Stern BJ
    Expert Rev Neurother; 2015 May; 15(5):533-48. PubMed ID: 25936846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis.
    Petereit HF; Reske D; Tumani H; Jarius S; Markus Leweke F; Woitalla D; Pfister HW; Rubbert A
    J Neurol; 2010 Nov; 257(11):1855-63. PubMed ID: 20556411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy.
    Marangoni S; Argentiero V; Tavolato B
    J Neurol; 2006 Apr; 253(4):488-95. PubMed ID: 16283095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of cerebrospinal fluid ACE level in aseptic meningitis: diagnostic?
    Saha BK; Saha A; Beegle S
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31451467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients.
    Sakushima K; Yabe I; Nakano F; Yoshida K; Tajima Y; Houzen H; Maruo Y; Sasaki H
    J Neurol; 2011 Dec; 258(12):2163-7. PubMed ID: 21553080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and diagnosis of neurosarcoidosis - review article.
    Barreras P; Stern BJ
    J Neuroimmunol; 2022 Jul; 368():577871. PubMed ID: 35523055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
    Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
    JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.